Unasyn and Naproxen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Unasyn (ampicillin sodium; sulbactam sodium) and Naproxen (naproxen). Common drug interactions include chest pain among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Unasyn and Naproxen. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Unasyn?

Unasyn has active ingredients of ampicillin sodium; sulbactam sodium. eHealthMe is studying from 4,474 Unasyn users. Check the latest studies of Unasyn.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,033 Naproxen users. Check the latest studies of Naproxen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

21 people who take Unasyn and Naproxen together, and have interactions are studied.

Unasyn and Naproxen drug interactions.

What are the common drug interactions of Unasyn and Naproxen, by gender? *:

female:

  1. Chest pain
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Ligament sprain (ligament stretched)
  4. Wound necrosis (damaged cell of wound)
  5. Joint swelling
  6. Skin necrosis (skin damage)
  7. Abscess (pus)
  8. Compression fracture (fracture due to pressure caused by injury)
  9. Diarrhoea
  10. Haematuria (presence of blood in urine)

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Lung infection
  3. Emotional distress
  4. Fear
  5. Impaired work ability
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Quality of life decreased
  8. Renal failure (kidney dysfunction)
  9. Renal injury (kidney injury)
  10. Skeletal injury (bone and supporting muscle injury)

What are the common drug interactions of Unasyn and Naproxen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood immunoglobulin m increased
  2. Infectious mononucleosis (infection usually caused by the epstein-barr virus)
  3. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Death
  5. Decreased activity
  6. Emotional distress
  7. Fear
  8. Impaired work ability
  9. Quality of life decreased
  10. Renal failure (kidney dysfunction)

30-39:

  1. Abdominal pain upper
  2. Acute respiratory distress syndrome
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anisocytosis (patient's red blood cells are of unequal size)
  5. Anxiety
  6. Asthenia (weakness)
  7. Beta 2 microglobulin increased
  8. Blood calcium decreased
  9. Blood glucose increased
  10. Blood lactate dehydrogenase increased

40-49:

  1. Cancer pain
  2. Malignant ascites (a condition in which a person with cancer has an accumulation of fluid in the abdomen)
  3. Ovarian cancer (cancer of ovary)

50-59:

  1. Constipation
  2. Depression
  3. Dizziness
  4. Dyspepsia (indigestion)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Dysthymic disorder (mild chronic depression disorder)
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Epistaxis (bleed from the nose)
  10. Fall

60+:

  1. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  2. Insomnia (sleeplessness)
  3. Nocturia (the need to get up in the night to urinate)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 8 people, 38.10%
  2. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 8 people, 38.10%
  3. Gastritis (inflammation of stomach): 3 people, 14.29%
  4. Tumor Associated Fever: 2 people, 9.52%
  5. Stable Angina (a constant chest pain): 2 people, 9.52%
  6. Renal Cell Carcinoma (a kidney cancer): 2 people, 9.52%
  7. Pneumonia: 2 people, 9.52%
  8. Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 9.52%
  9. Hiv Infection: 2 people, 9.52%
  10. Cardiac Failure: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Unasyn and Naproxen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Unasyn and Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Unasyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Unasyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ampicillin sodium; sulbactam sodium and naproxen (the active ingredients of Unasyn and Naproxen, respectively), and Unasyn and Naproxen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: